ClinicalTrials.gov
public full text
Public Domain
ACY-7 Oral Administration of Acyline
We propose oral dosing of gastrointestinal permeation enhancement technology \[GIPET\] enhanced oral acyline at 20 mg everyday for one week to determine the steady-state (multiple-dose) pharmacokinetics of oral acyline in four normal, healthy young men.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients#902037
- Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation#870285
- A Study to Compare the Oral Absorption of ASP1941 Among Two Types of Tablets#1057244
- Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis#1112563
- A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.#879209
Record · ID 876141
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive